1LeBlanc HN, Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ, 2003,10: 66-75.
2Kim Y, Seol DW. TRAIL, a mighty apoptosis inducer. Mol Cells,2003, 15: 283-293.
3MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett, 2003, 139: 89-97.
4Kim Y, Sub N, Sporn M, et al. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J Biol Chem, 2002, 277: 22320-22329.
5Marini P, Jendrossek V, Durand E, et al. Molecular requirements for the combined effects of TRAIL and ionising radiation. Radiother Oncol, 2003, 68:189-198.
6Lin T, Zhang L, Davis J, et al. Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. Mol Ther, 2003,8:441-448.
10Thorbum A, Behbakht K, Ford H. TRAIL receptor - targeted therapeutics: resistance mechanisms and strategies to avoid them[ J]. Drug Resist Updat, 2008 Feb - Apr, 11 ( 1 - 2) : 17 - 24.
